Combining the established interactions for all the target genes in our study, we speculate that AKT could stand as the hub of downstream effector that is targeted by TGX221 in ccRCC, which leads to curbed cell cycle and proliferation (Fig. 6F). The gene discussed is AKT1; the disease is nonpapillary renal cell carcinoma.